Sign In  |  Register  |  About Menlo Park  |  Contact Us

Menlo Park, CA
September 01, 2020 1:28pm
7-Day Forecast | Traffic

  • Search Hotels in Menlo Park

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Edwards Lifesciences (NY: EW )

78.14 -0.07 (-0.09%)
Official Closing Price Updated: 7:00 PM EST, Jan 27, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,623,157
Open 78.38
Bid (Size) 77.05 (1)
Ask (Size) 79.09 (1)
Prev. Close 78.21
Today's Range 77.81 - 78.84
52wk Range 67.13 - 131.10
Shares Outstanding 619,400,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
2 Smartest Tech Stocks to Buy in 2022 and Beyond
The tech space is still bursting with opportunities for long-term investors. 
Via The Motley Fool
Jim Cramer Recommends These 5 Healthcare Stocks For 2023: 'Biggest Winners Were Boring, Consistent Operators'
Prominent market commentator Jim Cramer has recommended five healthcare stocks which he believes should be on investors’ shopping list for 2023. 
Via Benzinga

Performance

YTD
+5.21%
+5.21%
1 Month
+4.73%
+4.73%
3 Month
+7.88%
+7.88%
6 Month
-21.43%
-21.43%
1 Year
-28.44%
-28.44%

More News

Read More
JPMorgan To Rally Around 17%? Here Are 10 Other Price Target Changes For Tuesday
Via Benzinga
Expert Ratings for Edwards Lifesciences
Via Benzinga
Reata Pharmaceuticals To Jump 220%? Plus JP Morgan Predicts $51 For Las Vegas Sands
Via Benzinga
15 Analysts Have This to Say About Edwards Lifesciences
Via Benzinga
Why Edwards Lifesciences Stock Crashed 16% Today
Via The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For December 6, 2022
Via Benzinga
S&P 500 Component DexCom Set For Further Price, Earnings Growth
Via MarketBeat
Topics Stocks
Exposures US Equities
Benzinga's Top Ratings Upgrades, Downgrades For December 2, 2022
Via Benzinga
Edwards Life Sciences Stock Disaster Could Be Your Bounty
Via MarketBeat
Topics Death
Exposures COVID-19 Death
Cramer's Take On This Stock That's Down 53% Year-To-Date: 'I Think Long-Term. I Don't Want To Own It'
Via Benzinga
7 Stocks to Buy at the ‘Midterm Elections’ Bottom
Via InvestorPlace
Honeywell To $194? Plus Citigroup Slashes PT On This Stock By Over 93%
Via Benzinga
Weibo, XPeng, Li Auto And Other Big Losers From Friday
Via Benzinga
Why Pinterest Shares Jumped Around 14%; Here Are 69 Biggest Movers From Friday
Via Benzinga
Nasdaq Climbs 275 Points; S&P 500 Rises Over 2%
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
$1000 Invested In This Stock 5 Years Ago Would Be Worth $2,100 Today
Via Benzinga
Economic Challenges Hit Edwards Lifesciences Q3 Earnings, Guidance Lags Wall Street Estimates
Via Benzinga
Dow Jumps 600 Points; Crude Oil Down Over 1%
Via Benzinga
US Stocks Mostly Higher; Dow Surges 300 Points
Via Benzinga
Why Edwards Lifesciences Shares Are Trading Lower By Around 17%? Here Are 47 Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 28, 2022
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 MenloPark.com & California Media Partners, LLC. All rights reserved.